You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR REMIMAZOLAM BESYLATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for REMIMAZOLAM BESYLATE

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT04790734 ↗	Remimazolam Besylate in Mechanically Ventilated ICU Patients	Not yet recruiting	Wuhan Union Hospital, China	Phase 3	2021-03-01	The purpose of this study is to evaluate the efficacy and safety of remimazolam compared to propofol for sedation in mechanically ventilated ICU patients.
NCT04947345 ↗	The Availability and Safety Study of Remimazolam Besylate for Injection on Sedation of ERAS Patients	Not yet recruiting	Yichang Humanwell Pharmaceutical Co.,Ltd	Phase 3	2021-09-01	This trial intends to evaluate Remimazolam Besylate's availability and safety compared with propofol.
NCT04947345 ↗	The Availability and Safety Study of Remimazolam Besylate for Injection on Sedation of ERAS Patients	Not yet recruiting	Peking Union Medical College Hospital	Phase 3	2021-09-01	This trial intends to evaluate Remimazolam Besylate's availability and safety compared with propofol.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for REMIMAZOLAM BESYLATE

Condition Name

Chart
Table

Condition Name for REMIMAZOLAM BESYLATE
Intervention	Trials
Remimazolam Besylate	3
Sedation	3
General Anesthesia	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for REMIMAZOLAM BESYLATE
Intervention	Trials
Critical Illness	4
Obesity, Morbid	1
Spinal Diseases	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for REMIMAZOLAM BESYLATE

Trials by Country

Map
Table

Trials by Country for REMIMAZOLAM BESYLATE
Location	Trials
China	12
Korea, Republic of	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for REMIMAZOLAM BESYLATE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for REMIMAZOLAM BESYLATE
Clinical Trial Phase	Trials
Phase 4	8
Phase 3	4
Phase 2	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for REMIMAZOLAM BESYLATE
Clinical Trial Phase	Trials
Not yet recruiting	18
Recruiting	10
Completed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for REMIMAZOLAM BESYLATE

Sponsor Name

Chart
Table

Sponsor Name for REMIMAZOLAM BESYLATE
Sponsor	Trials
Wuhan Union Hospital, China	7
Seoul National University Hospital	4
Yichang Humanwell Pharmaceutical Co., Ltd., China	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for REMIMAZOLAM BESYLATE
Sponsor	Trials
Other	31
Industry	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.